SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-17-002562
Filing Date
2017-04-13
Accepted
2017-04-12 20:17:14
Documents
6
Period of Report
2017-05-30

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2231783zpre14a.htm PRE 14A 437376
2 G427526.JPG g427526.jpg GRAPHIC 11748
3 G5970.JPG g5970.jpg GRAPHIC 9084
4 G23492BGI001.JPG g23492bgi001.jpg GRAPHIC 899
5 G23492BGI002.JPG g23492bgi002.jpg GRAPHIC 826
6 G23492BGI003.JPG g23492bgi003.jpg GRAPHIC 900
  Complete submission text file 0001047469-17-002562.txt   471597
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37350 | Film No.: 17759029
SIC: 3841 Surgical & Medical Instruments & Apparatus